MoneyWorks4Me

Bajaj Healthcare - Quaterly Results

14 Aug 2024 Evaluate
The total revenue for the quarter ended June 2024 remained nearly unchanged at Rs. 1322.47 millions.Modest increase of 14.23% in the Net Profit was reported from. 70.26 millions to Rs. 80.26  millions.The company reported a good operating profit of 253.58 millions compared to 219.62 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 1322.47 1297.37 1.93 1322.47 1297.37 1.93 4734.18 6457.96 -26.69
Other Income 8.54 2.18 291.74 8.54 2.18 291.74 86.86 15.90 446.29
PBIDT 253.58 219.62 15.46 253.58 219.62 15.46 849.51 1129.52 -24.79
Interest 84.44 87.51 -3.51 84.44 87.51 -3.51 296.80 175.61 69.01
PBDT 169.14 132.11 28.03 169.14 132.11 28.03 109.43 953.91 -88.53
Depreciation 67.30 63.07 6.71 67.30 63.07 6.71 276.20 172.08 60.51
PBT 101.84 69.04 47.51 101.84 69.04 47.51 -166.77 781.83 -121.33
TAX 21.58 -1.22 -1868.85 21.58 -1.22 -1868.85 -23.49 146.50 -116.03
Deferred Tax 21.58 -1.22 -1868.85 21.58 -1.22 -1868.85 -37.05 -17.08 116.92
PAT 80.26 70.26 14.23 80.26 70.26 14.23 -143.28 635.33 -122.55
Equity 137.99 137.99 0.00 137.99 137.99 0.00 137.99 137.99 0.00
PBIDTM(%) 19.17 16.93 13.27 19.17 16.93 13.27 17.94 17.49 2.60
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1145.25
Cipla 1359.75
Lupin 2047.20
Zydus Lifesciences 1105.00
View more..